Impact of clinical characteristics and management on the prognosis of unselected heart failure patients. (Record no. 24641387)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01859 a2200541 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517020026.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201512s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1573-7241 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s10557-015-6572-y |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Eschalier, Romain |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20151215 |
| 245 00 - TITLE STATEMENT | |
| Title | Impact of clinical characteristics and management on the prognosis of unselected heart failure patients. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Cardiovascular drugs and therapy |
| Date of publication, distribution, etc. | Feb 2015 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 89-98 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adrenergic beta-Antagonists |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiotensin II Type 1 Receptor Blockers |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiotensin-Converting Enzyme Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cohort Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | France |
| General subdivision | epidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart Failure |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hospitalization |
| General subdivision | statistics & numerical data |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mineralocorticoid Receptor Antagonists |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chenaf, Chouki |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mulliez, Aurélien |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yalioua, Arab |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Clerfond, Guillaume |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Authier, Nicolas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vorilhon, Charles |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Citron, Bernard |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pereira, Bruno |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jean, Frédéric |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Souteyrand, Géraud |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Motreff, Pascal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eschalier, Alain |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lusson, Jean-René |
| 773 0# - HOST ITEM ENTRY | |
| Title | Cardiovascular drugs and therapy |
| Related parts | vol. 29 |
| -- | no. 1 |
| -- | p. 89-98 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10557-015-6572-y">https://doi.org/10.1007/s10557-015-6572-y</a> |
| Public note | Available from publisher's website |
No items available.